HIV-Tuberculosis co-infection in a public health unit in the city of Santo Domingo de los Tsáchilas

Authors

  • Icler Naun Sisalema-Aguilar Universidad Regional Autónoma de Los Andes “Uniandes” https://orcid.org/0000-0003-3584-9592
  • Bolivar Fernando Mena-Hidalgo Universidad Regional Autónoma de Los Andes “Uniandes”
  • Roberto Javier Aguilar-Berrezueta Universidad Regional Autónoma de Los Andes “Uniandes”
  • Alice Mishelle Mantilla Moreira Universidad Regional Autónoma de Los Andes “Uniandes”

Keywords:

COINFECTION, HIV, TUBERCULOSIS.

Abstract

Introduction: HIV infection has caused significant negative impacts on health due to its high morbidity and mortality..Thus, it is recognized as the ninth leading cause of death globally and the second most prevalent cause due to a single infectious agent, after tuberculosis.

Objective: to describe the clinical behavior of HIV-Tuberculosis co-infection in a Public Health unit in the city of Santo Domingo de los Tsáchilas in the period 2022. 

Methods: the design used in this study was descriptive, observational and descriptive. Using methods such as analysis synthesis and observation.

Results: the HIV-Tuberculosis interaction was determined in a series of cases extracted from a databaseofthe Internal Medicine Unit of a public health unitIn the city of Santo Domingo de los Tsáchilas, a series of cases characteristic of a mixed study was used. The main data extracted were: the percentage of affected people, with a higher proportion being male; the diagnostic methods used to confirm HIV-tuberculosis co-infection, among which were BK1, GenExpert and LAM.

Conclusions: the mortality rate of HIV-tuberculosis co-infection within the group was determined, in addition, the main diseases associated with co-infection were determined, which were Syphilis, Covid-19, Histoplasmosis, Acute Renal Failure, in this way the main interactive characteristics of HIV-tuberculosis co-infection in the aforementioned sample were determined.

Downloads

Download data is not yet available.

References

1. Espinoza-Chiong C, Quiñones-Laveriano DM, Llanos-Tejada F, Patrón-Ordóñez G, Cárdenas Matlin M, Mejia Christian R. Factores asociados a la coinfección por tuberculosis y virus de inmunodeficiencia humana en un hospital peruano. Rev Cubana Invest Bioméd [Internet]. 2021 Sep [citado 02/01/2025]; 40(3): 1–16.. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002021000400003&lng=es

2. Minesterio de salud publica. Ministerio de Salud Publica/Subsecretaria de vigilancia de la salud pública [Internet]. Ministerio; 2019 [cited 02/01/2025]. Available from: https://www.salud.gob.ec/wp-content/uploads/2020/11/gaceta_vih_2019-1.pdf

3. Ministerio de salud pública. Ministerio de salud pública. [Online].; 2018 [cited 02/01/2025]. Available from: https://www.salud.gob.ec/wp-content/uploads/2019/03/informe_anual_TB_2018UV.pdf

4. Sampieri RH. Metodologia de la investigación. 6 ed. México: McGRAW-HILL, INTERAMERICANA EDITORES, S.A. DE C.V.; 2014.

5. Murray , Rosenthal , Pfaller MAM. Microbiología médica. In: Murray PR, Rosenthal KS, Pfaller MAM. Microbiología médica. Barcelona: Elsevier; 2021. p. 226-240 ; 543 - 549.

6. Ministerio de Salud Pública del Ecuador. Prevención, diagnóstico y tratamiento de la infección por el virus de inmunodeficiencia humana (VIH) en embarazadas, niños, adolescentes y adultos. Guía de Práctica Clínica [Internet]. Quito: Ministerio de Salud Pública, Dirección Nacional de Normatización; 2019 [Citado 02/01/2025]. Disponible en: https://www.salud.gob.ec/wp-content/uploads/2019/06/gpc_VIH_acuerdo_ministerial05-07-2019.pdf

7. Ministerio de Salud Pública del Ecuador. Prevención, diagnóstico, tratamiento y control de la tuberculosis. Guía de Práctica Clínica. 2 ed. [Internet]. Quito. Dirección Nacional de Normatización; 2018 [Citado 02/01/2025]. Disponible en: https://www.salud.gob.ec/wp-content/uploads/2018/03/GP_Tuberculosis-1.pdf

8. García Vallejo F. La genotipificación y fenotipificación de la resistencia del virus de la inmunodeficiencia humana tipo I a los fármacos antirretrovirales. Colombia Médica [Internet]. 2003 [Citado 02/01/2025]; 34(3): 143-154. Disponible en: https://www.redalyc.org/pdf/283/28334307.pdf

9. Maulén Nancy P, Cifuentes O. Lucía. Genetic polymorphisms associated with innate immunity and to genetic susceptibility to tuberculosis. Rev. chil. enferm. respir [Internet]. 2018 [citado 25/01/2025]; 34(4): 226-235. Disponible en: https://www.scielo.cl/scielo.php?pid=S0717-73482018000400226&script=sci_arttext&tlng=en

10. Valencia CP, Canaval GE, Correa D, Marín D. Signos y síntomas en personas que viven con el virus del sida (PVVS). Colombia Médica [Internet]. 2007 [cited 02/01/2025]; 38(4): 365-374. Disponible en: http://www.scielo.org.co/pdf/cm/v38n4/v38n4a5.pdf

11. Ferrufino J. Patología de la tuberculosis pulmonar. Rev Méd Hered [Internet]. 1993 [citado 23/01/2025]; 4(2). Disponible en: https://revistas.upch.edu.pe/index.php/RMH/article/view/395

12. Estébanez-Muñoz M, Soto-Abánades C, Ríos-Blanco J, Arribas J. Actualización en la patología pulmonar relacionada con la infección VIH. Archivos de Bronc [Internet]. 2012 Apr [citado 23/01/2025]; 48(4): 126-132. Disponible en: https://www.archbronconeumol.org/es-actualizacion-patologia-pulmonar-relacionada-con-articulo-S0300289611003978

13. Abreu J. Hipótesis, método & diseño de investigación (hypothesis, method & research design). Daena: International Journal of Good Conscience [Internet]. 2012 Jul [citado 23/01/2025]; 7(2): 187-197. Disponible en: https://philpapers.org/rec/ABRHM

14. Gil Rivera MC. La base de datos. Importancia y aplicación en educación. Perfiles Educativos [Internet]. 1994 Jul [citado 23/01/2025]; (65). Disponible en: https://www.redalyc.org/pdf/132/13206506.pdf

Downloads

Published

2025-01-27

How to Cite

1.
Sisalema-Aguilar IN, Mena-Hidalgo BF, Aguilar-Berrezueta RJ, Mantilla Moreira AM. HIV-Tuberculosis co-infection in a public health unit in the city of Santo Domingo de los Tsáchilas. Rev Ciencias Médicas [Internet]. 2025 Jan. 27 [cited 2025 Sep. 18];29(1):e6642. Available from: https://revcmpinar.sld.cu/index.php/publicaciones/article/view/6642

Issue

Vol. 29 No. 1 (2025): Publicación Continua

Section

ORIGINAL ARTICLES

License

Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.

Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/